1. µµÀÔ
õ½ÄÀº “¸¸¼ºÀûÀÎ ±âµµ ¿°ÁõÀ» Ư¡À¸·Î ÇÏ´Â ´Ù¾çÇÑ ¾ç»óÀ» º¸ÀÌ´Â ÁúȯÀ̸ç, °¡º¯ÀûÀΠȣ±â½Ã ±â·ùÁ¦ÇÑ°ú ÇÔ²² ½Ã°£¿¡ µû¶ó Áߵ°¡ º¯Çϴ õ¸í, È£Èí°ï¶õ, °¡½¿ ´ä´äÇÔ, ±âħ°ú °°Àº È£Èí±â Áõ»óÀÇ º´·ÂÀÌ ÀÖ´Â °Í"À¸·Î Á¤ÀǵȴÙ.1,2 ¾ÆÅäÇÇ, ±âµµ °ú¹Î¼º µî°ú °ü·ÃµÈ À¯ÀüÀû ¿äÀΰú ¾Ë·¹¸£±â Ç׿ø, °¨¿°, Èí¿¬, °ø±â¿À¿°, ¼±¸ÈµÈ ½Ä½À°ü µîÀÇ È¯°æÀû ¿äÀο¡ ÀÇÇØ ±âµµÀÇ ¸¸¼º ¿°ÁõÀÌ ¹ß»ýÇÏ°Ô µÈ´Ù.2,3 õ½ÄÀº °èÀý ¶Ç´Â ¾ÇÈ ÀÎÀÚ µî¿¡ µû¶ó ´Ù¾çÇÏ°Ô º¯Çϴµ¥ ¾ÇÈÀÎÀڷδ ¿îµ¿, ¾Ë·¹¸£±âÇ׿ø ȤÀº Àڱؼº ¹°Áú, ³¯¾¾ º¯È, °¨±â °°Àº È£Èí±â ¹ÙÀÌ·¯½º °¨¿°, µµ½Ã »ýÈ° µîÀÌ ¾Ë·ÁÁ® ÀÖ´Ù.3
õ½ÄÀº ÈçÇÑ ¸¸¼ºÁúȯÀ¸·Î ¼¼°èÀûÀ¸·Î ¾à 3¾ï¸í ÀÌ»óÀÇ È¯ÀÚ°¡ ÀÖÀ¸¸ç, 2025³â¿¡´Â 4¾ï¸í ÀÌ»óÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÈ´Ù.4 °³º° ±¹°¡¿¡¼ º¸°íÇÑ ¿¬±¸µéÀ» º¸¸é ½º¿þµ§ÀÇ 7~16¼¼ÀÇ Ãµ½Ä À¯º´·üÀÌ 1985³â 10%, 1995³â 14.5%, 2005³â 14.2%·Î Áõ°¡Çß°í,5 ÀÌÅ»¸®¾ÆÀÇ 20~44¼¼ ¼ºÀΠõ½ÄÀ¯º´·ü 1990³âºÎÅÍ 2010³â±îÁö 4.1%¿¡¼ 6.6%·Î Áõ°¡Çß´Ù.6 ij³ª´Ù ¿ÂŸ¸®¿ÀÁÖÀÇ ¼ºº°°ú ¿¬·ÉÀ» º¸Á¤ÇÑ Ãµ½Ä À¯º´·üÀº 1996³â 8.5%¿¡¼ 2005³â 13.3%·Î Áõ°¡Çß´Ù.7 Anandan µîÀÌ º¸°íÇÑ Ãµ½ÄÀÇ À¯º´·ü ÃßÀÌ¿¡ ´ëÇÑ systematic review¿¡¼´Â 48°³ ¿¬±¸¸¦ ºÐ¼®ÇÑ °á°ú Àü¼¼°èÀûÀÎ À¯º´·üÀÌ Áõ°¡ÇÏ°í ÀÖ´Ù°í º¸°íÇß´Ù.8 ¶ÇÇÑ 1990³âºÎÅÍ 2016³â±îÁöÀÇ Àü¼¼°è Áúº´ÀÇ ºÎ´ã¿¡ ´ëÇÑ ¿¬±¸¿¡¼ õ½ÄÀÇ À¯º´·üÀº 2006³âºÎÅÍ 2016³â±îÁö 17.2% Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù.9 µµ½ÃÈ µîÀÇ È¯°æÀûÀÎ ¿äÀΰú ½Ä½À°ü, ¾àÁ¦, Á¤½Å»çȸÀûÀÎ ¿©·¯ ¿äÀε鿡 ÀÇÇØ Ãµ½ÄÀÇ À¯º´·üÀº Àü¼¼°èÀûÀ¸·Î Áõ°¡ÇÏ°í ÀÖ´Ù.10 º» ³í°í¿¡¼´Â ±¹³» õ½Ä À¯º´·ü ÃßÀ̸¦ »ìÆ캸°í ÇâÈÄ º¯µ¿ ¿äÀο¡ ´ëÇØ ¾Ë¾Æº¸°Ú´Ù.
2. º»¹®
±¹³» õ½Ä À¯º´·üÀº Áõ°¡ÇÏ°í Àִµ¥ ÀÌ´Â ÁÖ·Î ¾î¸°ÀÌ¿Í °í·ÉÃþÀÇ À¯º´·ü Áõ°¡¿¡ ±âÀÎÇÑ °ÍÀÌ´Ù. ±¹¹Î°Ç°¿µ¾çÁ¶»ç¿¡¼ ¼Ò¾Æ õ½Ä À¯º´·üÀº Áõ°¡ÇÏ°í ÀÖÁö¸¸ Áõ°¡ Ãß¼¼°¡ Á¡Â÷ ¿ÏÈµÅ¾î °¡°í ÀÖ´Ù. 2000³âµµ ISAAC Á¶»ç¿¡¼ Æò»ý õ½Ä À¯º´·üÀº 6~11¼¼ 13.0%, 12~15¼¼ 12.8% ¿´°í, ÃÖ±Ù 12°³¿ùÀÇ Ãµ½Ä À¯º´·üÀº 6~12¼¼°¡ 4.9%, 12~15¼¼´Â 9.3%·Î È®ÀεƴÙ.11 2011³â Àü±¹ ÃʵîÇб³ ´ë»óÀ¸·Î ¼öÇàµÈ Àü±¹´ÜÀ§ÀÇ ¿ªÇÐÁ¶»ç¿¡¼ Æò»ý õ½Ä À¯º´·üÀº 10.3%¿´´Ù.12
´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ õ½Ä¿¬±¸È¸¿¡¼ 1998³â Àü±¹ ¼ºÀÎ 8823¸íÀ» ´ë»óÀ¸·Î Áö³ 12°³¿ù°£ õ¸íÀÌ ÀÖ¾ú´ÂÁö¿¡ ´ëÇØ ¼³¹®Á¶»çÇÑ °á°ú ±¹³» ¼ºÀΠõ½Ä À¯º´·üÀº 12.8%¿´´Ù.13 ±¹¹Î°Ç°Á¶»çÀÇ ÀÇ»ç Áø´Ü õ½ÄÀÇ À¯º´·üÀº 1998³â 0.7%¿¡¼ 2008³â 2.0%·Î Áõ°¡Çß°í ÇöÀç õ½Ä ¾àÁ¦¸¦ »ç¿ëÇÏ´Â »ç¶÷ÀÇ ºñÀ²µµ 0.3%¿¡¼ 0.7%·Î ´Ã¾î³µ´Ù.14 ±¹¹Î°Ç°¿µ¾çÁ¶»çÀÇ Ãµ½Ä À¯º´·üÀº 2002³âºÎÅÍ 2013³â±îÁö ²ÙÁØÇÏ°Ô Áõ°¡ÇÏ´Â °æÇâÀ» º¸ÀÌ°í ÀÖÀ¸¸ç ¿¬µµ¿Í ¹«°üÇÏ°Ô ¿©¼ºÀÌ ³²¼º¿¡ ºñÇØ À¯º´·üÀÌ Áö¼ÓÀûÀ¸·Î ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ´Ù (±×¸² 1).15 ƯÈ÷ 65¼¼ ÀÌ»óÀÇ ³ëÀÎ Àα¸¿¡¼´Â ³ôÀº À¯º´·üÀ» º¸¿´´Ù.
õ½Ä À¯º´·üÀÇ °á°ú°¡ ´Ù¾çÇÏ°Ô ³ª¿À´Â °ÍÀº ¿ì¼± õ½Ä ÀÚü°¡ ÀÌÁúÀûÀÎ Áúº´±ºÀ̸ç, ÀÇ»çÀÇ ÆÇ´Ü¿¡ ÀÇÇØ ÀÓ»óÀûÀ¸·Î Áø´ÜµÇ±â ¶§¹®ÀÌ´Ù. ÀÏ°üµÈ Áø´Ü ±âÁØÀÌ ¾ø´Âµ¥ ±¹¹Î°Ç°¿µ¾çÁ¶»ç µîÀÇ ¼³¹® Á¶»ç´Â ȯÀÚÀÇ ±â¾ï¿¡ ÀÇÁ¸ÇϹǷΠ½ÇÁ¦ÀÇ À¯º´·üÀ» ¹Ý¿µÇϱ⿡´Â ¹«¸®°¡ ÀÖÀ» ¼ö¹Û¿¡ ¾ø´Ù. ¶ÇÇÑ ±¹°¡ ¼öÁØÀÇ ºÐ¼®À» À§ÇØ ±¹¹Î°Ç°º¸Çè°ø´ÜÀ̳ª °Ç°º¸Çè½É»çÆò°¡¿øÀÇ Ã»±¸ÀڷḦ ÀÌ¿ëÇÒ ¼ö ÀÖÀ¸³ª ÀÌ´Â ½ÇÁ¦ Áúº´ÀÌ ¾Æ´Ñ ó¹æ¿¡ ÀÇÁ¸Çϱ⠶§¹®¿¡ Çؼ®¿¡ ÁÖÀÇ°¡ ÇÊ¿äÇÏ´Ù. ¿¹¸¦ µé¸é ¼Ò¾Æ¿¡¼ õ½Ä À¯º´·üÀÌ Áõ°¡ÇÏ´Â °ÍÀÌ ÈíÀÔ±â ó¹æÀ» À§ÇÑ »óº´ ÀԷ°ú ¿¬°ü¼ºÀÌ ÀÖÀ» ¼ö ÀÖ´Ù.
±×·¯³ª ÀÌ·± ÇѰ踦 °¨¾ÈÇÏ´õ¶óµµ ±¹³» õ½Ä À¯º´·ü¿¡ ´ëÇÑ ¿ªÇÐ ¿¬±¸µéÀ» Á¾ÇÕÇØ º¸¸é(Ç¥ 1) õ½Ä À¯º´·üÀÌ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÏ´Â Ãß¼¼ÀÓÀ» ¾Ë ¼ö ÀÖ´Ù. ±× ¿øÀÎÀ¸·Î µµ½ÃÈ Áõ°¡, ¼±¸ÀûÀÎ ½Ä»ýÈ° ½À°ü, ½Åü ºñ¸¸Áö¼ö Áõ°¡ µîÀÇ »ýÈ° ȯ°æ º¯È°¡ ÀÖÀ¸¸ç10 ´ë±â¿À¿°, ¹Ì¼¼¸ÕÁöÀÇ Áõ°¡ µîÀÇ ´ë±â ȯ°æ º¯Èµµ ¹ÐÁ¢ÇÑ °ü°è°¡ ÀÖ´Ù.17 ±¹³»¿¡¼ ºñ±³Àû ¸¹ÀÌ ÀÌ·ç¾îÁö´Â Á¦¿ÕÀý°³°¡ ½Å»ý¾ÆÀÇ ¸é¿ª ±âÀü¿¡ ¿µÇâÀ» ¹ÌÃÄ Ãµ½ÄÀÌ Áõ°¡ÇÑ´Ù´Â º¸°íµµ ÀÖ´Ù.16
ÇâÈÄÀÇ »çȸÀû, ȯ°æÀû º¯È¸¦ °í·ÁÇßÀ» ¶§ õ½ÄÀÇ À¯º´·üÀº ÇâÈÄ¿¡µµ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÒ °¡´É¼ºÀÌ ³ô´Ù. ´ë±â¿Âµµ »ó½Â, °¡¹³°ú Æø¿ì¿Í °°Àº ³¯¾¾ÀÇ ±ØÇÑ º¯µ¿, °¿ì·®ÀÇ º¯È¿Í °°Àº ±âÈÄ º¯È´Â ´ë±â¿À¿°¹°Áú¿¡ ¿µÇâÀ» ¹ÌÃÄ Ãµ½ÄÀÇ À¯º´·ü Áõ°¡¸¦ ÃÊ·¡ÇÑ´Ù.18 ´ë±â¿À¿°¹°Áú Áß Ãµ½Ä¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Â °ÍÀ¸·Î´Â ¹Ì¼¼¸ÕÁö19, ¿ÀÁ¸20, Áú¼Ò»êȹ°21, ÀÌ»êÈȲ22 µîÀÌ ÀÖ´Ù. Àα¸±¸Á¶ÀÇ º¯È ¶ÇÇÑ Ãµ½ÄÀÇ À¯º´·üÀ» Áõ°¡½ÃŲ´Ù. ÇöÀç õ½Ä À¯º´·üÀÌ ³ëÀÎÀα¸¿¡¼ ³ôÀºµ¥ Àα¸±¸Á¶°¡ Á¡Â÷ °í·ÉÈ µÇ°í ÀÖÀ¸¹Ç·Î õ½Ä À¯º´·ü ¶ÇÇÑ Áõ°¡ÇÒ °ÍÀÌ´Ù.23 À̹ÎÀÚÀÇ Áõ°¡ ¶ÇÇÑ Ãµ½Ä À¯º´·ü¿¡ ¿µÇâÀ» ¹ÌÄ£´Ù. 2005³â Kamal µîÀÇ ¿¬±¸¿¡ ÀÇÇÏ¸é ´Ù¾çÇÑ ÀÎÁ¾Àº ȯ°æ ¹× »îÀÇ ¹æ½Ä º¯È¿Í ÇÔ²² õ½Ä À¯º´·ü Áõ°¡¿Í °ü·ÃÀÌ ÀÖ´Ù.24 Á¡Á¡ ½ÉÇØÁö´Â »çȸ ¾ç±ØÈ·Î ÀÎÇÑ ºó°ïÃþÀÇ Áõ°¡µµ õ½ÄÀÇ À¯º´·ü°ú °ü°è°¡ ÀÖ´Ù.25
3. °á·Ð
õ½ÄÀº ÈçÇÑ ¸¸¼ºÁúȯÀ¸·Î µµ½ÃÈÀÇ ÁøÇà°ú ¹Ì¼¼¸ÕÁö µîÀÇ È¯°æÀûÀÎ ¿äÀÎ, ½Ä½À°ü µîÀÇ ¿©·¯ °¡Áö ¿äÀεé·Î ÃÖ±Ù Àü¼¼°èÀûÀ¸·Î Áõ°¡ÇÏ´Â Ãß¼¼´Ù. ¶ÇÇÑ ±¹³»¿¡¼µµ õ½ÄÀÇ À¯º´·üÀº ¿¬·Éº°·Î ´Ù¸£Áö¸¸ ÀüüÀûÀ¸·Î´Â Áõ°¡ÇÏ´Â ¾ç»óÀ» º¸ÀÌ°í ÀÖ´Ù. ±¹³» 64¼¼ ÀÌÇÏÀÇ ¼ºÀο¡¼´Â Àü¹ÝÀûÀ¸·Î Áõ°¡ÇÏ´Â ¾ç»óÀ̸ç 65¼¼ ÀÌ»óÀÇ °í ¿¬·É ±º¿¡¼´Â Áö¼ÓÀûÀ¸·Î À¯º´·üÀº ³ôÁö¸¸ ¿¬µµº° ÃßÀÌ´Â º¯µ¿ÀÌ ÀÖ¾ú´Ù. 19¼¼ ¹Ì¸¸ÀÇ ¼Ò¾Æ¿¡¼´Â Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÏ´Â ¾ç»óÀ¸·Î È®ÀεǾú´Ù. »çȸÀÇ ¹ßÀü°ú ÇÔ²² õ½ÄÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ°í ÀÌ¿¡ ´ëÇÑ »çȸ°æÁ¦Àû ºÎ´ãÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµÈ´Ù. ÀÌ¿¡ ±¹°¡ ¼öÁØÀÇ Ãµ½Ä À¯º´·ü ¹× ½ÇÅÂÆľÇÀ» À§ÇÑ Á¶»ç°¡ ÇÊ¿äÇϸç õ½Ä °ü¸®°¡ ÇʼöÀûÀ¸·Î ÀÌ·ç¾îÁ®¾ß ÇÒ °ÍÀÌ´Ù.
References
1. Global Initiative for Asthma: global strategy for asthma management and prevention. Global Initiative For Asthma, 2019. (Accessed April 14, 2019, at https://ginasthma.org/.)
2. British Thoracic S, Scottish Intercollegiate Guidelines N. British guideline on the management of asthma. Thorax 2014;69 Suppl 1:1-192.
3. Busse WW, Lemanske RF, Jr. Asthma. N Engl J Med 2001;344:350-62.
4. Bousquet J, Dahl R, Khaltaev N. Global Alliance against Chronic Respiratory Diseases. Eur Respir J 2007;29:233-9.
5. Kalvesten L, Braback L. Time trend for the prevalence of asthma among school children in a Swedish district in 1985-2005. Acta Paediatr 2008;97:454-8.
6. de Marco R, Cappa V, Accordini S, et al. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J 2012;39:883-92.
7. Gershon AS, Guan J, Wang C, To T. Trends in asthma prevalence and incidence in Ontario, Canada, 1996-2005: a population study. Am J Epidemiol 2010;172:728-36.
8. Anandan C, Nurmatov U, van Schayck OC, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 2010;65:152-67.
9. G. B. D. Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. The lancet Respiratory medicine 2017;5:691-706.
10. Sears MR. Trends in the prevalence of asthma. Chest 2014;145:219-25.
11. Hong SJ, Lee MS, Sohn MH, et al. Self-reported prevalence and risk factors of asthma among Korean adolescents: 5-year follow-up study, 1995-2000. Clin Exp Allergy 2004;34:1556-62.
12. Suh M, Kim HH, Sohn MH, Kim KE, Kim C, Shin DC. Prevalence of allergic diseases among Korean school-age children: a nationwide cross-sectional questionnaire study. Journal of Korean medical science 2011;26:332-8.
13. Park HS, Choi GS, Cho JS, Kim YY. Epidemiology and current status of allergic rhinitis, asthma, and associated allergic diseases in Korea: ARIA Asia-Pacific workshop report. Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 2009;27:167-71.
14. Cho SH, Park HW, Rosenberg DM. The current status of asthma in Korea. Journal of Korean medical science 2006;21:181-7.
15. ±¹°¡Åë°èÆ÷ÅÐ, õ½Ä ÀÇ»çÁø´Ü°æÇè·ü ÃßÀÌ: ¸¸19¼¼ÀÌ»ó. 2019. (Accessed 2019/04/10, at http://kosis.kr/statHtml/statHtml.do?orgId=117&tblId= DT_11702_N112&conn_path=I2.)
16. Thavagnanam S, Fleming J, Bromley A, Shields MD, Cardwell CR. A meta-analysis of the association between Caesarean section and childhood asthma. Clin Exp Allergy 2008;38:629-33.
17. Beggs PJ. Adaptation to impacts of climate change on aeroallergens and allergic respiratory diseases. International journal of environmental research and public health 2010;7:3006-21.
18. D'Amato G, Liccardi G, D'Amato M, Cazzola M. Outdoor air pollution, climatic changes and allergic bronchial asthma. Eur Respir J 2002;20:763-76.
19. Jo EJ, Lee WS, Jo HY, et al. Effects of particulate matter on respiratory disease and the impact of meteorological factors in Busan, Korea. Respir Med 2017;124:79-87.
20. McConnell R, Berhane K, Gilliland F, et al. Asthma in exercising children exposed to ozone: a cohort study. Lancet 2002;359:386-91.
21. Khreis H, Kelly C, Tate J, Parslow R, Lucas K, Nieuwenhuijsen M. Exposure to traffic-related air pollution and risk of development of childhood asthma: A systematic review and meta-analysis. Environment international 2017;100:1-31.
22. Sheppard D, Wong WS, Uehara CF, Nadel JA, Boushey HA. Lower threshold and greater bronchomotor responsiveness of asthmatic subjects to sulfur dioxide. Am Rev Respir Dis 1980;122:873-8.
23. Hanania NA, King MJ, Braman SS, et al. Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol 2011;128:S4-24.
24. Eldeirawi K, McConnell R, Freels S, Persky VW. Associations of place of birth with asthma and wheezing in Mexican American children. J Allergy Clin Immunol 2005;116:42-8.
25. Wright RJ. Epidemiology of stress and asthma: from constricting communities and fragile families to epigenetics. Immunol Allergy Clin North Am 2011;31:19-39.
26. Kim SY, Jung JY, Park MS, et al. Increased prevalence of self-reported asthma among Korean adults: an analysis of KNHANES I and IV data. Lung 2013;191:281-8.
THE MOST webmaster@mostonline.co.kr
<ÀúÀÛ±ÇÀÚ © THE MOST, ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>